CNMD vs INSP
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CNMD · ConMed$46.56 ▲ 0.39%
INSP · Inspire Medical Systems$55.10 ▼ 2.10%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CNMD +7.5%
- INSP -53.0%
Head to head
| Metric | CNMD | INSP |
|---|---|---|
| Price | $46.56 | $55.10 |
| Change today | ▲ 0.39% | ▼ 2.10% |
| Market cap | $1.39B | $1.60B |
| Return, 3 months | -9.6% | -10.4% |
| Return, year to date | +14.7% | -40.3% |
| Return, 1 year | +8.8% | -38.7% |
| P/E (TTM) | 19.3 | 16.4 |
| P/B | 1.3 | 1.9 |
| P/E percentile vs own 5y | 49th | 69th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -0.7% | -7.9% |
| Net profit growth (YoY) | +592.4% | -345.6% |
| Gross margin | 57.6% | 86.2% |
| Operating margin | 9.9% | 1.8% |
| Net margin | 5.4% | 11.4% |
| Return on equity | 7.1% | 13.5% |
| Analyst target vs. price | +6.3% | +35.0% |
| Analyst buy share | 0% | 33% |
| RSI (14) | 43 | 27 |
| 30-day volatility | 53.1% | 46.5% |
| Max drawdown, 1 year | -30.3% | -72.2% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- INSP is the largest of the group by market value.
- CNMD has returned the most over the past year.
- INSP carries the lowest trailing P/E.
- CNMD is growing revenue fastest.
- INSP keeps the most profit per dollar of sales.
- INSP has been the calmest stock over the last 30 days.